Enzymatic
Δ1-dehydrogenation mediated by 3-ketosteroid-Δ1-dehydrogenases (Δ1-KstDs, EC 1.3.99.4) offers
an attractive method to access pharmaceutically important Δ1-3-ketosteroids by avoiding the multistep chemical reactions
and use of toxic reagents. However, Δ1-KstDs have
low or no activity toward C6-substituted and other bulky 3-ketosteroids,
which limits their applications in the synthesis of the corresponding
dehydrogenated products that are widely used for the treatment of
different diseases. Herein, structure-based site-directed saturation
mutagenesis of KstD from Propionibacterium sp. (PrKstD)
was performed to tune its substrate specificity. Amino acid residues
potentially responsible for substrate recognition were site-directedly
mutated, and the results showed that the residues H135, A356, and
S422 played important roles in fine-tuning the substrate specificity.
Especially, the release of the steric effect of H135 provided extra
space for accommodating the substrate with C6 methyl for a higher
efficiency of transferring hydride at the active site. A double variant
of PrKstD (H135T/A356N) exhibited 16.7-fold increased catalytic efficiency
compared to that of the wild-type enzyme toward 6α-methyl-11β,17α-dihydroxy-4-pregnene-3,20-dione
(1g). Molecular dynamics simulations provide some insights
into the roles of the key mutations in the enhanced activity. Furthermore,
Δ1-dehydrogenation of 6α-methyl-11β,17α-dihydroxy-4-pregnene-3,20-dione
(1g) was scaled from gram to kilogram scale with high
substrate loading (60.0 g·L–1) at a space–time
yield of 4.08 g·L–1·h–1, much higher than the previously reported results. This work offers
not only an effective method for the Δ1-dehydrogenation
of C6-substituted 3-ketosteroids to furnish the corresponding bulky
Δ1-3-ketosteroids but also guidance for tuning the
substrate profile of 3-ketosteroid-Δ1-dehydrogenases
to access other pharmaceutically relevant Δ1-3-ketosteroids
in a green way.